2H-Pyran-2-one, 6-heptyltetrahydro-, (6R)-
Common Name: |
2H-Pyran-2-one, 6-heptyltetrahydro-, (6R)- |
IUPAC Name: |
(6R)-6-heptyloxan-2-one |
Molecular Formula: |
C10H18O2 |
SMILES: |
CCCCCCCC1CCCC(=O)O1 |
Inchi: |
1S/C12H22O2/c1-2-3-4-5-6-8-11-9-7-10-12(13)14-11/h11H,2-10H2,1H3/t11-/m1/s1 |
Inchi Key: |
QRPLZGZHJABGRS-LLVKDONJSA-N |
Cas No: |
29587-89-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
170.25 |
Mass (g/mol) |
198.162 |
Molar Refractivity |
49.35 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
295.00 to 296.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.002 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
3.443 |
iLOGP |
2.53 |
XLOGP3 |
2.54 |
WLOGP |
2.66 |
MLOGP |
2.19 |
ESOL Log S |
-2.23 |
ESOL Solubility (mg/ml) |
0.998 |
ESOL Solubility (mol/l) |
0.006 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.74 |
Ali Solubility (mg/ml) |
0.31 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.67 |
Silicos-IT Solubility (mg/ml) |
0.37 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.54 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.698 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.62 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |